Nathaniel Herzfeld

Array ( [id] => 10405328 [patent_doc_number] => 20150290338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'AFFINITY PEPTIDE-MODIFIED PARTICLES AND TARGETED DRUG DELIVERY METHODS' [patent_app_type] => utility [patent_app_number] => 14/437113 [patent_app_country] => US [patent_app_date] => 2013-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3769 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11276032 [patent_doc_number] => 09492503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Surfactant protein D for the treatment of disorders associated with lung injury' [patent_app_type] => utility [patent_app_number] => 14/062682 [patent_app_country] => US [patent_app_date] => 2013-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8064 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14062682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10348891 [patent_doc_number] => 20150233896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'Plasma H2S Levels as Biomarkers for Vascular Disease' [patent_app_type] => utility [patent_app_number] => 14/435231 [patent_app_country] => US [patent_app_date] => 2013-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5626 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14326561 [patent_doc_number] => 10294284 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-21 [patent_title] => Method for preparing C1q recombinant protein [patent_app_type] => utility [patent_app_number] => 14/434385 [patent_app_country] => US [patent_app_date] => 2013-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 7320 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9281320 [patent_doc_number] => 20140031288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'NOVEL COMPOSITION FOR TUMOR GROWTH CONTROL' [patent_app_type] => utility [patent_app_number] => 14/044293 [patent_app_country] => US [patent_app_date] => 2013-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6603 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14044293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9491871 [patent_doc_number] => 20140142277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS' [patent_app_type] => utility [patent_app_number] => 14/042226 [patent_app_country] => US [patent_app_date] => 2013-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25206 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14042226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9561279 [patent_doc_number] => 20140178993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'Method and applications of peptide-mediated mitochondrial delivery system' [patent_app_type] => utility [patent_app_number] => 14/036597 [patent_app_country] => US [patent_app_date] => 2013-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4009 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14036597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10656469 [patent_doc_number] => 20160002613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'Cell Penetrating Peptide, Conjugate Comprising Same, and Composition Comprising Conjugate' [patent_app_type] => utility [patent_app_number] => 14/429641 [patent_app_country] => US [patent_app_date] => 2013-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 11985 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14429641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9777950 [patent_doc_number] => 08853154 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Fibronectin based scaffold domain proteins that bind to myostatin' [patent_app_type] => utility [patent_app_number] => 14/025307 [patent_app_country] => US [patent_app_date] => 2013-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 56986 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14025307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10356434 [patent_doc_number] => 20150241440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'METHODS AND COMPOSITIONS FOR SITE-SPECIFIC LABELING OF PEPTIDES AND PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/426599 [patent_app_country] => US [patent_app_date] => 2013-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 33397 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14426599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9263220 [patent_doc_number] => 20130345149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'SILICONE-BASED OPHTHALMIC FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 13/972070 [patent_app_country] => US [patent_app_date] => 2013-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 46154 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13972070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10355226 [patent_doc_number] => 20150240231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'ISOLATING TRAFFIC-ENHANCING MUTANTS OF DRUG DELIVERY PROTEIN' [patent_app_type] => utility [patent_app_number] => 14/419233 [patent_app_country] => US [patent_app_date] => 2013-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 5389 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11779136 [patent_doc_number] => 09388231 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-12 [patent_title] => 'Multivalent heteromultimer scaffold design and constructs' [patent_app_type] => utility [patent_app_number] => 13/941450 [patent_app_country] => US [patent_app_date] => 2013-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 75 [patent_no_of_words] => 53002 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13941450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9174974 [patent_doc_number] => 20130316959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'USE OF ENDOSTATIN PEPTIDES FOR THE TREATMENT OF FIBROSIS' [patent_app_type] => utility [patent_app_number] => 13/939058 [patent_app_country] => US [patent_app_date] => 2013-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 24728 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13939058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9135511 [patent_doc_number] => 20130296226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/931827 [patent_app_country] => US [patent_app_date] => 2013-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17950 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13931827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9951151 [patent_doc_number] => 08999938 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-07 [patent_title] => 'Ophthalmic lipophilic drug delivery vehicle formulations' [patent_app_type] => utility [patent_app_number] => 13/924189 [patent_app_country] => US [patent_app_date] => 2013-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8712 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13924189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10692419 [patent_doc_number] => 20160038565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'Methods of Mitigating Side Effects of Radiation Exposure and Chemotherapy' [patent_app_type] => utility [patent_app_number] => 14/408165 [patent_app_country] => US [patent_app_date] => 2013-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19181 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14408165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9191107 [patent_doc_number] => 20130330422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'METHODS FOR INCREASING INSULIN SENSITIVITY AND TREATING DIABETES WITH A BIOACTIVE CHROMIUM BINDING PEPTIDE' [patent_app_type] => utility [patent_app_number] => 13/912356 [patent_app_country] => US [patent_app_date] => 2013-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11193 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13912356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9643157 [patent_doc_number] => 20140221270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'Methoxypolyethyleneglycol succinimidyl propionate modified recombinant ganoderma immunoregulatory protein, preparing method and application thereof' [patent_app_type] => utility [patent_app_number] => 14/119042 [patent_app_country] => US [patent_app_date] => 2013-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3846 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14119042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10280002 [patent_doc_number] => 20150164998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'Insulin Analogue Or Its Pharmaceutically Acceptable Salt, Pharmaceutical Composition With Prolonged Therapeutic Effect, Use Of The Insulin Analogue, Dosage Method and Method of Treatment of Diabetes' [patent_app_type] => utility [patent_app_number] => 14/403513 [patent_app_country] => US [patent_app_date] => 2013-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18496 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403513 [rel_patent_id] =>[rel_patent_doc_number] =>)